The FDA just changed the game for peptides. April 2026 The FDA is reviewing Category 2 peptides for potential removal from restricted status. Full approval for some peptides may be Peptide BPC 157 Does It Work? Breaking Down the Evidence and the Hype FDA Peptide Reclassification 2026: What Researchers Want FDA Peptide Reclassification 2026: What It Means for Providers FDA Puts BPC 157, TB 500, and 5 Other Peptides Under the Microscope: What Prescribers Need to Know About the 503A Review Lengea